$150.00 Original price was: $150.00.$9.00Current price is: $9.00.
Written by Sarfaraz K. Niazi, this book is a thorough and complete treatise on nucleic acid therapeutic products, including mRNA vaccines, their manufacturing, formulations, and testing for safety and efficacy.
This book provides in-depth details on cGMP-compliant manufacturing and regulatory filing steps, ensuring that readers are well-equipped to navigate the complexities of nucleic acid product development.
A novel concept of biosimilar mRNA vaccine is presented, offering a pathway to fast-track approval of mRNA vaccine copies. Additionally, the book provides financial plans for establishing RNA manufacturing facilities, as well as insights into supply chain management.
The book presents a forward-looking perspective on the role of nucleic acid products in gene therapy and other emerging applications. It is projected that all new vaccines will be of the nucleic acid type, providing first-time prevention of autoimmune disorders.
Both big pharma and start-ups are expected to enter this field, leading to significant additions to our drug armamentarium in the near future.
Publisher: CRC Press
1st edition: December 6, 2022
Language: English
Hardcover: 304 pages
ISBN-10: 1032163445
ISBN-13: 978-1032163444
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline